2.6. Kinase Profiling Assay

JM Jin Ma
JR Jiang Ren
MT Midory Thorikay
MD Maarten van Dinther
GS Gonzalo Sanchez-Duffhues
JC Josselin Caradec
PB Pascal Benderitter
JH Jan Hoflack
PD Peter ten Dijke
request Request a Protocol
ask Ask a question
Favorite

The kinase inhibition profile of the compounds was determined by testing 96 protein kinases’ activity using a radiometric protein kinase assay (33 PanQinase® Activity Assay, Proqinase, Germany). In brief, 10 µL of non-radioactive ATP solution (in H2O), 25 µL of assay buffer/[γ-33 P]-ATP mixture, 5 µL of 0.1 μM the tested compound in 10% DMSO and 10 µL of enzyme/substrate were mixed in 96-well FlashPlatesTM (Perkin Elmer, Boston, MA, USA). The reaction was conducted at 30 °C for 60 min. To stop the reaction, 50 µL of 2% (v/v) H3PO4 was added into the protein kinase reaction cocktails. After which, with 200 µL 0.9% (w/v) NaCl twice, the incorporation of 33 Pi (counting of “cpm”) was determined with a microplate scintillation counter (Wallac Microbeta, Boston, MA, USA). All protein kinase assays were performed using a BeckmanCoulter Biomek 2000/SL robotic system (Brea, CA, USA). The residual activity (in %) for each compound was normalized to 100% enzyme activity (untreated control) and background (negative control).

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A